Inquis Medical develops the AVENTUS Precision Thrombectomy System, which provides a solution for the non-surgical removal of emboli and thrombi from blood vessels.

Inquis Medical

Inquis Medical, Inc. | 1,124 followers on LinkedIn. Inquis Medical, Inc. is a privately clinical stage medical device company based in Silicon Valley. Our company legacy is built on decades of developing, launching, and supporting novel, physician-tested medical devices that address unmet needs, with a long-lasting impact. Inquis Medical’s team is focused on improving the management of venous thromboembolic diseases.

Steve Miller

Erik Engelson

Eyal Aklivanh

Neuroscience | Machine Learning | Medical Devices

Diane Whitmer, Ph.D.

Inquis Medical, Inc.

Thank you to everyone who joined us at #VIVA24 and #TheVEINS24 ! A special thanks to Dr. Samuel Horr for his presentation on the AVENTUS Thrombectomy System. It was exciting to connect with all the experts dedicated to advancing VTE treatment and we look forward to making an even bigger splash at VIVA/VEINS next year!

Proud to announce that Inquis Medical has raised $40 million in Series B funding to advance our Aventus Thrombectomy System. Grateful for the support of our investors and the dedication of our team as we work to transform VTE care. https://lnkd.in/gjdVZQkT #InquisMedical #HealthcareInnovation #VTE #medtech #vascular #interventionalcardiology #interventionalradiology

Join us at #VIVA24 & #TheVEINS24 at the Wynn, Las Vegas, and discover the future of pulmonary embolism treatment! Don’t miss the AVENTUS Thrombectomy System presentation by Dr. Samuel Horr at the Blue Sky Breakfast Session at Lafleur 1 Ballrooms on Sunday, November 3rd, 2024.

Thank you to everyone who joined us at #TCT2024 ! Special thanks to Dr. Jun Li and University Hospitals Cleveland for the live case presentation of the AVENTUS Thrombectomy System. It was a great opportunity to highlight our innovative solution in action!

Congratulations to Dr. Christopher Laing, Dr. Henal Patel, and the dedicated team at Sutter Health for successfully completing their 1st AVENTUS case. #PulmonaryEmbolism #Thrombectomy #InquisMedical #AVENTUS #Cardiology #InterventionalCardiology

Join us at the Endovascular Spotlight Room at #TCT2024 | October 30th for a live case presentation of the AVENTUS Thrombectomy System by Dr. Jun Li from University Hospitals Cleveland. Don’t miss this opportunity to see our innovative solution in action!

Congratulations to Dr. Joseph Ingrassia, Dr. Saurabh Joshi, and the dedicated team at Hartford Hospital for successfully completing their 1st AVENTUS case. #PulmonaryEmbolism #Thrombectomy #InquisMedical #AVENTUS #Cardiology #InterventionalCardiology

We're at #PERTConsortium2024 in Boston this week, where Dr. Jun Li, National Co-PI of the AVENTUS trial, will present an exciting case on the AVENTUS Thrombectomy System. If you’re at the conference, don’t miss the presentation at the PERT Poster Session. Date: September 12th Time: 5:00 - 6:00 PM ET We look forward to connecting with you there!

Congratulations to Dr. Bart Dolmatch, Dr. Fabio Komlos, and the dedicated team at El Camino Health for successfully completing their 1st AVENTUS case. #PulmonaryEmbolism #Thrombectomy #InquisMedical #AVENTUS . #Cardiology #InterventionalCardiology

Congratulations to Dr. Saba Lahsaei and the dedicated team at NorthBay Medical Center for successfully completing their 1st AVENTUS case. #PulmonaryEmbolism #Thrombectomy #InquisMedical #AVENTUS #Cardiology #InterventionalCardiology

Google Maps

reCAPTCHA

CrUX Dataset

CrUX Top 50m

Gravity Forms

Director of Systems and Electrical Engineering

Michael Pare

Director of Research and Development

Richard Ewers

Operations

Robert Tucker

Manager Clinical Affairs

Nisu Patel

R&D Manager

Richard Childs

Principal R&D Engineer

Erik Jagger

VP of Marketing

Jennifer Wong

West Coast Early Stage Companies With Fewer Than 1000 Employees

San Francisco Bay Area Early Stage Companies With Fewer Than 50 Employees

Western US Startups (Top 10K)

California Startups Founded in 2019

Inquis Medical is developing thrombectomy technology, enabling an efficient single-pass thrombectomy with minimal blood loss.

Marshall Wace

Series B - Inquis Medical

Venture Round - Inquis Medical

Seed Round - Inquis Medical

Redwood City

California

United States

North America

The Week’s Biggest Funding Rounds: Slow Week Produces Small Venture Rounds

Inquis Medical Announces $40 Million Series B Financing to Accelerate Advancement of Aventus Thrombectomy System Addressing Venus Thromboembolic Diseases

Inquis Medical, Inc. on LinkedIn: #pulmonaryembolism #thrombectomy #inquismedical #aventus #cardiology…

Apparatuses and methods for tracking obstructive material within a suction …

Aspiration apparatuses for clot removal

Devices, systems, and methods for removing obstructive material from body …

India

Asia

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 9, 2024 10:48 AM	a0ba9851
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 9, 2024 10:48 AM	ccbe774c
crunchbase trigger	general	Nov 9, 2024 10:48 AM	bc6a8174
crunchbase profile	general	Nov 9, 2024 8:14 PM	98641339
li profile	general	Nov 9, 2024 10:48 AM	d7b9e5fb
translate crunchbase fundingrounds	general	Nov 9, 2024 9:08 PM	3eb8d323
peers	general	Nov 9, 2024 10:48 AM	d7d0665b
news basic	general	Nov 9, 2024 10:48 AM	1580a844
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

INQU

COM:INQUISMEDICAL

Inquis Medical